Literature DB >> 8843430

An isogenic haemolysin-deficient mutant of Haemophilus ducreyi lacks the ability to produce cytopathic effects on human foreskin fibroblasts.

K L Palmer1, W E Goldman, R S Munson.   

Abstract

The haemolysin of Haemophilus ducreyi is the newest member of the Proteus/Serratia family of pore-forming toxins. In order to assess the role of the haemolysin in virulence, we constructed an isogenic haemolysin-deficient mutant of H. ducreyi strain 35000 This strain, designated 35000-3, lacks detectable haemolytic activity. We tested H. ducreyi strains 35000 and 35000-3 for their cytopathic activity against human foreskin fibroblasts (HFFs). We observed strong cytopathic activity when strain 35000 was co-cultured with HFFs. In contrast, cytopathic activity was not observed when strain 35000-3 was co-cultured with HFF cells. We also analysed the isogenic pair of H. ducreyi strains for cytopathic activity against HeLa cells and the keratinocyte cell line HaCaT. Strains 35000 and 35000-3 were strongly cytotoxic when co-cultured with HeLa cells. HaCaT monolayers were slightly damaged by cocultivation with strain 35000-3 but this damage was much less than that observed when HaCaT cells were cocultured with strain 35000. These results indicate that the H. ducreyi haemolysin is responsible for the previously observed cytotoxic activity against HFF cells and is partially responsible for the activity observed with HaCaT cells. The haemolysin, however, is not responsible for the activity observed with HeLa cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8843430     DOI: 10.1046/j.1365-2958.1996.00615.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  35 in total

Review 1.  Immunopathogenesis of Haemophilus ducreyi infection (chancroid).

Authors:  Stanley M Spinola; Margaret E Bauer; Robert S Munson
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

2.  The LspB protein is involved in the secretion of the LspA1 and LspA2 proteins by Haemophilus ducreyi.

Authors:  Christine K Ward; Jason R Mock; Eric J Hansen
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

3.  Immune cells are required for cutaneous ulceration in a swine model of chancroid.

Authors:  L R San Mateo; K L Toffer; P E Orndorff; T H Kawula
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

4.  Identification of tandem genes involved in lipooligosaccharide expression by Haemophilus ducreyi.

Authors:  M K Stevens; J Klesney-Tait; S Lumbley; K A Walters; A M Joffe; J D Radolf; E J Hansen
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

5.  Haemophilus ducreyi infection causes basal keratinocyte cytotoxicity and elicits a unique cytokine induction pattern in an In vitro human skin model.

Authors:  M M Hobbs; T R Paul; P B Wyrick; T H Kawula
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

6.  Cloning and characterization of the lipooligosaccharide galactosyltransferase II gene of Haemophilus ducreyi.

Authors:  S Sun; B Schilling; L Tarantino; M V Tullius; B W Gibson; R S Munson
Journal:  J Bacteriol       Date:  2000-04       Impact factor: 3.490

7.  Identification of a novel sialic acid transporter in Haemophilus ducreyi.

Authors:  Deborah M B Post; Rachna Mungur; Bradford W Gibson; Robert S Munson
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

8.  Involvement of the Haemophilus ducreyi gmhA gene product in lipooligosaccharide expression and virulence.

Authors:  B A Bauer; M K Stevens; E J Hansen
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  Identification and characterization of the N-acetylglucosamine glycosyltransferase gene of Haemophilus ducreyi.

Authors:  Shuhua Sun; N Karoline Scheffler; Bradford W Gibson; Jing Wang; Robert S Munson
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

10.  Inhibition of phagocytosis by Haemophilus ducreyi requires expression of the LspA1 and LspA2 proteins.

Authors:  Merja Vakevainen; Steven Greenberg; Eric J Hansen
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.